Daidzein_NN
and_CC
genistein_NN
glucuronides_NNS
in_FW
vitro_FW
are_VBP
weakly_RB
estrogenic_JJ
and_CC
activate_VBP
human_JJ
natural_JJ
killer_NN
cells_NNS
at_IN
nutritionally_RB
relevant_JJ
concentrations_NNS
._.

Daidzein_NN
and_CC
genistein_NN
glucuronides_NNS
-LRB-_-LRB-
DG_NNS
and_CC
GG_NNS
-RRB-_-RRB-
,_,
major_JJ
isoflavone_NN
metabolites_NNS
,_,
may_MD
be_VB
partly_RB
responsible_JJ
for_IN
biological_JJ
effects_NNS
of_IN
isoflavones_NNS
,_,
such_JJ
as_IN
estrogen_NN
receptor_NN
binding_NN
and_CC
natural_JJ
killer_NN
cell_NN
-LRB-_-LRB-
NK_NN
-RRB-_-RRB-
activation_NN
or_CC
inhibition_NN
._.

DG_NNS
and_CC
GG_NNS
were_VBD
synthesized_VBN
using_VBG
3-methylcholanthrene-induced_JJ
rat_NN
liver_NN
microsomes_NNS
._.

The_DT
Km_NN
and_CC
Vmax_NN
for_IN
daidzein_NN
and_CC
genistein_NN
were_VBD
9.0_CD
and_CC
7.7_CD
micromol\/L_NN
,_,
and_CC
0.7_CD
and_CC
1.6_CD
micromol_NN
\/_:
-LRB-_-LRB-
mg_NN
protein_NN
._.
min_NN
-RRB-_-RRB-
,_,
respectively_RB
._.

The_DT
absence_NN
of_IN
ultraviolet_JJ
absorbance_NN
maxima_NN
shifts_NNS
in_IN
the_DT
presence_NN
of_IN
sodium_NN
acetate_NN
confirmed_VBD
that_IN
the_DT
synthesized_VBN
products_NNS
were_VBD
7-O-glucuronides_JJ
._.

DG_NNS
and_CC
GG_NNS
were_VBD
further_RB
purified_VBN
by_IN
a_DT
Sephadex_NN
LH-20_NN
column_NN
._.

DG_NNS
and_CC
GG_NNS
competed_VBD
with_IN
the_DT
binding_NN
of_IN
17beta_NN
-_:
-LRB-_-LRB-
3H_NN
-RRB-_-RRB-
estradiol_NN
to_TO
estrogen_NN
receptors_NNS
of_IN
B6D2F1_NN
mouse_NN
uterine_NN
cytosol_NN
._.

The_DT
concentrations_NNS
required_VBN
for_IN
50_CD
%_NN
displacement_NN
of_IN
17beta_NN
-_:
-LRB-_-LRB-
3H_NN
-RRB-_-RRB-
estradiol_NN
-LRB-_-LRB-
CB50_NN
-RRB-_-RRB-
were_VBD
:_:
17beta-estradiol_NN
,_,
1.34_CD
nmol\/L_NN
;_:
diethylstilbestrol_NN
,_,
1.46_CD
nmol\/L_NN
;_:
daidzein_NN
,_,
1.6_CD
micromol\/L_NN
;_:
DG_NNS
,_,
14.7_CD
micromol\/L_NN
;_:
genistein_NN
,_,
0.154_CD
micromol\/L_NN
;_:
GG_NNS
,_,
7.27_CD
micromol\/L_NN
._.

In_IN
human_JJ
peripheral_JJ
blood_NN
NK_NN
cells_NNS
,_,
genistein_NN
at_IN
&lt;_JJR
0.5_CD
micromol\/L_NN
and_CC
DG_NNS
and_CC
GG_NNS
at_IN
0.1-10_CD
micromol\/L_NN
enhanced_VBD
NK_NN
cell-mediated_JJ
K562_NN
cancer_NN
cell_NN
killing_NN
significantly_RB
-LRB-_-LRB-
P_NN
&lt;_JJR
0.05_CD
-RRB-_-RRB-
._.

At_IN
&gt;_JJR
0.5_CD
micromol\/L_NN
,_,
genistein_NN
inhibited_VBD
NK_NN
cytotoxicity_NN
significantly_RB
-LRB-_-LRB-
P_NN
&lt;_JJR
0.05_CD
-RRB-_-RRB-
._.

The_DT
glucuronides_NNS
only_RB
inhibited_VBD
NK_NN
cytotoxicity_NN
at_IN
50_CD
micromol\/L_NN
._.

Isoflavones_NNS
,_,
and_CC
especially_RB
the_DT
isoflavone_NN
glucuronides_NNS
,_,
enhanced_VBD
activation_NN
of_IN
NK_NN
cells_NNS
by_IN
interleukin-2_NN
-LRB-_-LRB-
IL-2_NN
-RRB-_-RRB-
,_,
additively_RB
._.

At_IN
physiological_JJ
concentrations_NNS
,_,
DG_NNS
and_CC
GG_NNS
were_VBD
weakly_RB
estrogenic_JJ
,_,
and_CC
they_PRP
activated_VBD
human_JJ
NK_NN
cells_NNS
in_IN
nutritionally_RB
relevant_JJ
concentrations_NNS
in_FW
vitro_FW
,_,
probably_RB
at_IN
a_DT
site_NN
different_JJ
from_IN
IL-2_NN
action_NN
._.

